⌘K
Loading ticker…
As of 2026-09-10, Neuraxis, Inc. (NRXS) has a 3-month relative strength percentile of 24 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 62. The current market Stance is 15.8 (Defensive). Sector: Healthcare, ranked 3 of 11. Average daily range 4.1%, relative volume 0.72×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
NRXS is in a stage 3 topping pattern, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -12.7% / -5.2%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
NRXS is held by 3 ETFs as of Jun 2026. Top owner: VTI at 0.00% weight, $2M notional. Top 3 carry $3M.
Held by 3 ETFs · $3M across latest filings · largest weight 0.01% (IWC).
Top 3 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $2M | — |
| VXFVanguard Extended Market ETF | 0.00% | $729K | — |
| IWC | 0.01% | $215K | new |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Related searches
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NRXS Jan avg: -2.27% median: -6.37% win: 33% σ: 7.50% n: 3 2023-08-10 → 2026-08-31 | NRXS Feb avg: 22.87% median: 39.56% win: 67% σ: 30.91% n: 3 2023-08-10 → 2026-08-31 | NRXS Mar avg: 3.79% median: -1.38% win: 33% σ: 17.54% n: 3 2023-08-10 → 2026-08-31 | NRXS Apr avg: 4.18% median: 2.56% win: 100% σ: 4.54% n: 3 2023-08-10 → 2026-08-31 | NRXS May avg: 5.63% median: 1.25% win: 67% σ: 9.17% n: 3 2023-08-10 → 2026-08-31 | NRXS Jun avg: -8.97% median: -11.36% win: 0% σ: 6.75% n: 3 2023-08-10 → 2026-08-31 | NRXS Jul avg: 3.44% median: 8.26% win: 67% σ: 16.08% n: 3 2023-08-10 → 2026-08-31 | NRXS Aug avg: -10.38% median: -4.72% win: 0% σ: 12.46% n: 4 2023-08-10 → 2026-08-31 | NRXS Sep avg: 2.63% median: -2.56% win: 33% σ: 16.65% n: 3 2023-08-10 → 2026-08-31 (current) | NRXS Oct avg: -23.81% median: -11.69% win: 0% σ: 22.71% n: 3 2023-08-10 → 2026-08-31 | NRXS Nov avg: 26.35% median: 10.52% win: 100% σ: 34.86% n: 3 2023-08-10 → 2026-08-31 | NRXS Dec avg: 8.95% median: -15.51% win: 33% σ: 47.16% n: 3 2023-08-10 → 2026-08-31 |